Purpose Our aim was to analyze, in a multivariate framework, how sociodemographic, health-service utilization, health needs, and lifestyle risk factors influence drug utilization and polypharmacy (PP) in a general population in Greece. Methods The cross-sectional study took place in 2006. In total 1,005 individuals (>18 years old) of 1,388 who were approached (response rate 72.4%) were interviewed by trained interviewers. Thirty-seven reported only over-thecounter (OTC) drug use and were excluded. The final sample was 968 individuals. Multivariable logistic regression and multinomial regression analyses were conducted to determine the predictors of drug use and PP at a significance level of p<0.05. Results The results revealed a high rate of drug use and PP. Drug use and PP were more common among women and increased with age. Advanced age 65+ [odds ratio (OR) 11.6), university education (OR 2.3), visits to physician (OR 2.2), comorbidity (OR 6.8), or poor physical and mental health were associated with higher likelihood of using drugs. Minor (two to three drugs) and major (four or more drugs) PP depended on comorbidity, physical health, and increased age. Furthermore, visits to physicians (OR 1.1), smoking (OR 3.0), and obesity (OR 3.8) increased the likelihood of major PP. Conclusions Overall, drug utilization and PP depended on health needs followed by education, utilization of health services, and age. Social disparities do persist and, after adjustments for health needs and obesity, had a significant influence on PP.
Introduction
Drug utilization is the most common medical intervention to reduce a variety of health risk factors (e.g., cardiovascular), prevent acute events, and treat diseases. Variation in the pattern of drug utilization, large pharmaceutical consumption-polypharmacy (PP)-with adverse drug reactions (ADRs) and increased trends in pharmaceutical expenditures are some of the major concerns for health care systems. Many studies have focused on the prevalence of drug use, covering several factors that may influence utilization. Gender differences have been extensively investigated, as well as utilization among elderly people, who are the major drug users [1] [2] [3] [4] [5] [6] . Socioeconomic characteristics, health status, and health risk factors are important determinants of variations in drug utilization [1, [7] [8] [9] [10] [11] [12] [13] [14] . However, few studies have investigated drug utilization in a multivariate framework involving all the above-mentioned variables [1, 8, 12] .
PP surveys, on the other hand, are age specific and focused on the elderly population. Previous studies have investigated the determinants of PP, reporting sociodemographic [15] [16] [17] [18] , medically related [16] [17] [18] [19] , and health system factors [20] as significant predictors of PP use or the adverse effects of PP, such as drug reactions and the increasing risks of hospitalization [21] [22] [23] . There is a lack of consensus on the specific number of drugs required to define PP, which has been defined as simultaneous use of more than one prescribed drug and classified as minor (two to four drugs) and major (five or more drugs) [15] , or as long-term use of two or more drugs for at least 60 days per quarter per year [24] . Other studies define PP as six to nine drugs and excess PP as ten or more drugs) [25] or that includes over-the-counter (OTC) remedies [16] .
In Greece, previous studies on drug utilization are limited and are population and area specific [26, 27] , whereas PP has not been investigated thus far. Drug consumption is very high, and there is a rapid increase in pharmaceutical expenditures as a proportion of total health expenditures. According to Organization for Economic Cooperation and Development (OECD) data [28] , in 2006, pharmaceutical expenditures amounted to 24.8% of total health expenditures, whereas in 1997, this proportion was 16.2%. Political measures, such as the list, to control the growth of pharmaceutical expenditure proved ineffective [29] . It is therefore important to study how drugs are used by the population and which factors affect drug utilization, taking into account social aspects or whether drugs are being used according to health needs. This study was undertaken to cover the absence of surveys on medicine utilization and PP in Greece by investigating the prevalence of the self-reported general use of prescribed drugs and PP. Furthermore, we evaluated, in a multivariate framework, the combined effect of various factors found in previous studies, such as sociodemographics, use of health services, health needs, and health risk factors relating to lifestyle, on the use of prescription drugs and on PP in a representative sample of the general population.
Materials and methods

Study and data
The cross-sectional study took place in September 2006 and involved a sample of adults (>18 years old) residing in urban (>2,000 inhabitants) and rural (<2,000 inhabitants) areas of the country and each of the 13 geographic regions. According to the latest Population Census (2001), the population of the surveyed regions consisted of approximately 8,880,924 individuals. Nonfluent Greek speakers, institutionalized individuals, and those incapable of reasoning and decision making on their own were excluded. Participants were grouped, in proportion to the Greek population, by sociodemographic characteristics according to a three-staged sampling methodology. In the first stage, a random sample of building blocks was selected in proportion to family size. In the second stage, households were randomly selected by systematic sampling. In the third stage, an eligible participant was selected by simple random sampling in each household. In total 1,005 willing individuals of 1,388 initially approached (response rate 72.4%) were interviewed by trained interviewers. Thirtyseven of 1,005 participants reported taking only OTC drugs, and they were excluded from the analysis because they represented a small group. The reported OTC drugs were analgesics, anti-inflammatory agents, and antacids. The study focused on the 968 participants. This health survey covered a wide range of information. The questionnaire consisted of five main parts: health-related quality of life measured by the Short Form (SF)-36 Health Survey, health behavior, morbidity, utilization of health services (including drug use), and sociodemographic characteristics.
Measurements
Prescribed drug utilization was measured by the question: "Do you currently take some sort of medication on a daily basis"? It was explained to the participants that "currently" referred to the previous 14 days, whereas "daily basis" meant regular or continuous intake of medicines. Answers yes or no to the above question represented use or no use of drugs, respectively. Furthermore, the interviewer recorded the name of the drugs, the dosage form (tablets or injections), and the extent of consumption (e.g., the number of drugs taken). PP was defined as simultaneous use of more than one drug and classified as minor (two to three drugs) and major (four or more drugs). All reported drugs were classified under one of the following categories: antihypertensives, antithrombotics, hypolipidemics, antidiabetics, insulin, analgesics, laxatives, and psychotropics.
Sociodemographic characteristics
The demographic characteristics were measured by the three categorical variables of gender, age, and marital status. Education and occupation were the two variables measuring the socioeconomic status of the participants. Educational level was classified into three levels: primary (reference category), secondary, and university levels. Occupation was recorded by asking the participants to choose the position best describing their current employment from a list that included employer, employee, retired, other (unemployed, students, and housewives, as reference category). Participants also reported their place of residence (urban/rural).
Health service utilization
Participants were asked to report the number of visits to a general physician, a specialist, or a hospital outpatient clinic or whether they had been admitted to hospital during the previous 12 months. Up to three visits was considered normal use, whereas four or more visits were thought of as high use of health services. Regarding hospitalization, any use (admission) was contrasted to no use.
Health-needs factors
Health needs were measured by the following proxy variables: self-assessed health, comorbidity, and health risks. Self-assessed health was measured by the Greek version of SF-12, which has been validated in a national representative general population sample in a previous study [30] . With the SF-12 we assessed the physical and mental health of the respondents on a scale of 0-100, with higher scores reflecting better perceived physical and mental health. Comorbidity was based on the presence or absence (and number) of chronic diseases. Respondents were asked to report whether they suffered from at least one of the following 13 chronic diseases: diabetes mellitus type I or II, hypertension, hyperlipidamia, heart failure, coronary ischemic disease, irritable bowel syndrome, chronic bronchitis, asthma, osteoarthritis, Alzheimer's, depression, and anxiety disorders. Chronic disease was a continuous variable ranging from 0 (no chronic disease) to five chronic diseases (the highest reported number).
Health risks, such as smoking and alcohol consumption, behaviors that stem from the individual's harmful lifestyle and which are believed to contribute to the development of illness and to impaired health, were also assessed. Participants were asked if they were smokers and they were classified as nonsmokers or daily/occasionally smokers. Information about alcohol consumption was based on the question: "How many portions (e.g. a glass of wine) of alcoholic beverages on average do you consume per week"? Respondents were classified as consuming up to seven glasses of wine per week or consuming more. Finally, we assessed obesity, which is another independent variable that constitutes a contemporary disease associated with chronic diseases such as diabetes and cardiovascular disease, as well as health risks such as physical inactivity and unhealthy nutrition. Obesity was assessed by the body mass index (BMI), and respondents were regarded as either normal (BMI<25), overweight (25≤BMI<30) or obese (BMI≥30).
Statistical analysis
After selecting the factors that possibly determine drug use and PP according to the literature, a chi-square test was used to assess whether prevalence of drug utilization and PP differed across sociodemographic characteristics. Multivariable stepwise logistic regression analysis was conducted to determine the predictors of drug utilization. A logistic regression model, using forward Wald selection, was run, and we used the exponentiation of B coefficient Exp(b) in order to estimate the adjusted odds ratio (OR) for each independent factor (sociodemographic, utilization of health care, health-need proxies) with 95% confidence intervals (CI). Multinomial logistic regression analysis using forward stepwise selection was further applied to analyze the impact of the independent variables on minor and major PP, with the reference category corresponding to those taking one drug. Results were considered statistically significant when p<0.05. All analyses were performed using SPSS v17.0. Oral informed consent was obtained from the participants before the interview. The study was approved by the ethics committee of the Hellenic Open University.
Results
Prevalence of drug use and polypharmacy
Four hundred one respondents (i.e., 41.6%) were drug users taking at least one drug every day. Approximately 26% of the sample reported taking more than one drug, whereas this proportion among drug users was 61.92%. Almost 28% of the sample had made more than four visits to a physician, whereas 11.4% reported that they had been hospitalized during the previous 12 months ( Table 1) . The proportion of drug users increased with increasing age in both genders (χ 2 -test, p<0.0001) (Fig. 1) . Women used more medicines than men in each age group, but gender differences were statistically significant only in the older age groups of 55-64 and 65+ years (p<0.01), with women having higher likelihood of using drugs (data not shown).
The number of drugs taken also increased with increasing age (χ 2 test, p<0.0001) (Fig. 2) . Taking 1 or 2-3 drugs increased with age starting from the ages between 18 and 24, where taking one drug was the most common case, whereas taking four or more drugs occurred in the age group from 35 to 44 and increased rapidly with age, which was expected, and confirmed that PP is associated with older age. Regarding the reported drugs (data not shown), antihypertensives were the most common drugs taken.
Univariate analysis (Table 2) showed that all sociodemographic variables were significantly associated with drug utilization, whereas PP was associated only with age, marital status, education level, and employment status. Multinomial logistic regression analysis (Table 4 )-performed by assessing the OR for minor or major PPshowed that in the case of minor PP, the only significant predictors were age, comorbidity, and physical health. Advanced age increased the odds of taking two to three drugs by a factor of 10% (in multinomial analysis, age was used as continuous variable). Having at least one chronic disease (and for each increase) the odds of using two to three drugs increased twofold (OR 2.0, 95% CI 1.109-3.776), whereas for each unit increase in physical health (PCS 12) the odds decreased by 10% (OR 0.9, 95% CI 0.927-0.983). Concerning major PP, with each increase in the number of chronic diseases, the odds of using four or more drugs increased almost ten times (OR 9.6, 95% CI 2.612-35.322), whereas with each unit increase in physical (PCS 12) and mental (MCS 12) health, the odds of using four or more drugs were decreased by 10%. Age was also a predictor, as with each year increase, the odds of using four or more drugs increased by 5.9%. More health care visits increased the probability of major PP by a factor of 10%. Among lifestyle characteristics, only smoking was significantly related to major PP, with smokers being almost three times more likely to take four or more drugs. Finally, obesity (BMI≥30) increased the probability of major PP by a factor of 3.8. Obese individuals were almost four times more likely to use four drugs compared with individuals with normal weight.
Discussion
This study was conducted with a cross-sectional design using face-to-face interviews to collect information on drug utilization and PP in a representative sample of the Greek general population. It was undertaken to cover the absence of studies related to drug utilization and PP in Greece. This study adds new knowledge by examining the combined effect of various variables on drug use and especially on PP. Previous studies on medicine utilization in a multivariate framework in representative general populations are few [1, 8, 12] , and as far as we know, PP has not been studied in a multivariable framework. The results revealed a high rate of drug use and PP. Antihypertensives were the most commonly taken drugs, as hypertension is the most common chronic disease, its prevalence is high [31] , and there is a need for daily treatment. A key finding was that social disparities in medicine use exist in the Greek general population. Education was a strong predictor, with a higher educational level increasing the likelihood of medication use after adjustment for health need and health-service factors. This finding was not in accordance with previous studies, which found a weak influence of education and an inverse association with medicine use [1, 11, 12] . The reduced use of medicines by less-educated individuals is a concern, as low education is related to poor health [32] , and therefore, this segment of the population is more vulnerable. A crucial question is why these differences still exist and whether they are due to the patients or to physician/ health-system characteristics. The reduced use may represent under-or inappropriate treatment for the less educated and may reflect poorer communication with physicians (as education influences attitudes and knowledge) or noncompliance to doctors' advice. It is therefore of great importance to acquire more knowledge about the process leading to social inequalities in drug use in order to take the appropriate measures, ensuring equal treatment for all individuals. Finally, our study did not confirm findings from previous studies [16] [17] [18] about the relationship between low educational level and PP.
The effect of health need, measured by morbidity and self-assessed health (i.e., physical and mental health) was significant as expected. Morbidity/comorbidity and physical and mental health were strong predictors of medicine use and PP. This is in accordance with results from previous studies [8, 12, 16, 25, 33] and support findings that morbidity and self-assessed health are important determinants. It is reasonable to assume that people who rate their health as poor or using diagnosis reporting that they suffer from at least one chronic disease had a higher likelihood of using drugs or were more prone to PP in cases of severe illness or several diseases. An important viewpoint is that mental health is associated with major PP, and this is realistic, as mental diseases are likely to be exposed to excess multiple drug treatment.
A large number of visits to a doctor, i.e. more than four times within the previous12 months, increased the likelihood of medicine use and major PP after adjustment for morbidity and self-assessed health. In our sample, 40% of those reporting visiting a doctor had made more than four visits within the last year. This high health-service utilization implies an enormous cost for the health care system, which constitutes a very important issue for Greece, where the pharmaceutical expenditures have increased rapidly and impose a huge burden on health care budgets.
In agreement with previous studies, we found that medicine use was more common among women than men and increased with increasing age [1, 3, 8, 12, 16] . Multivariate analysis, after adjusting for other independent variables such as comorbidity and health-service utilization, showed that gender differences were statistically insignificant. This indicates a weak effect of gender on drug use, with health need (comorbidity) and health-service utilization as confounders in the association between gender and drug utilization. However, by analyzing gender differences according to age, we observed that women were more likely than men to use medicines in the advanced age groups (data not shown) and the increased age-related morbidity is the most obvious explanation. PP is associated with increasing age, a finding that is common in previous studies and is confirmed by the fact that the majority of studies regarding PP focus the research on elderly populations.
Subsequently, our analysis found that BMI affected major PP. Association between obesity and drug use was found previously [7, 16] . It is reasonable to assume that a high BMI (≥30) is associated with higher drug use, as obesity was thought to be a contemporary disease that threatens peoples' health and their quality of life and is correlated with poor health and many chronic diseases such as diabetes. On the other hand, chronic diseases such as diabetes, cardiovascular diseases, or depression may lead to physical inactivity and rising BMI. Furthermore, the relationship between obesity, PP, and higher risk of hospitalization is of great importance to be studied. In our study, we found that health risks such as smoking affected major PP, a finding that is in accordance with a previous study among older men [16] , whereas results from another previous study showed greater general drug use by smokers [1] . The relationship between smoking and several severe diseases, such as cardiovascular diseases or cancer, is the obvious explanation.
There are some limitations in our study. The sampling strategy focused on households, so a specific population having a greater need and higher utilization of drugs and of PP, such as institutionalized individuals, was excluded. However, this strategy was followed by the majority of health-care utilization studies. Moreover, people reporting only OTC medicines were excluded from our analysis because they constituted a small group (37 individuals). A larger sample of OTC users would permit us to separately analyze the utilization of the two different types of medicine and compare the results. As mentioned before, daily/regular use may exclude drugs taken occasionally, and this could be a possible limitation of our study. There may be an underestimation of PP, as daily/regular use left out occasionally taken drugs (sleep medication, analgesics, etc.), but in our study, the portion of PP (minor and major) amounted to almost 62% of drug users. The high rate of reported PP minimizes the risk of underestimation and contributes to the quality of the data.
Methodological considerations
One of the most important methodological issues in investigating drug utilization through questionnaires is the recall period. As suggested in a previous study [34] , there is no consistency in the literature about the ideal recall period, whereas the prevalence of drug use is dependent on the recall period. Furthermore, another previous study [35] showed that the accuracy of recall of drugs taken decreased with increasing age and the increasing number of medicines. In drug utilization studies, the recall period varied from 1 [7, 9] to 14 [1 days, 8] . In our study we asked respondents about daily (regular) use during the "current period," which was defined as the previous 14 days. As this study deals with daily use, there may be minor problems with recall bias, minimizing the problem of remembering the drugs taken and their exact number. As stated, validity of self-reported data composes a question in drug utilization studies. In this study, we hypothesized that all drugs used were reported correctly by the interviewees and that the high response rate (72.4) contributes to data quality and to the validity of the results.
